State Sen. April Weaver (R-Brierfield) pre-filed legislation for the 2026 legislative session recently that would ban psychoactive THC hemp products in Alabama.
According to the legislation, existing law lists tetrahydrocannabinol (THC) as a Schedule I controlled substance, but explicitly exempts THC found in hemp. Delta-8 THC, Delta-9 THC, and Delta-10 THC are psychoactive cannabinoids that can be made from hemp-derived cannabidiol (CBD). The bill would provide that only nonpsychoactive cannabinoids derived from or found in hemp are exempt from the Schedule I controlled substances list, thus classifying psychoactive cannabinoids as controlled substances. The bill would provide that products that are ingested, whether orally or absorbed through the skin, that contain CBD or other nonpsychoactive cannabinoids found in or derived from hemp may only be sold in licensed pharmacies that obtain certification from the Alabama State Board of Pharmacy.
“When it comes to morals, values, and protecting our children from gateway drugs, Alabama will lead the way to avoid repeating the mistakes that other states have made,” Weaver told 1819 News in a recent interview. “I have heard first-hand from so many of my constituents how these drugs have had a terrible effect on their children and their families. I think we need to continue the conversations and help people understand the safety impact these high-potency psychoactive THC products have on our communities.”
To connect with the author of this story or to comment, email [email protected].
Don’t miss out! Subscribe to our newsletter and get our top stories every weekday morning.
